{
    "name": "apraclonidine",
    "comment": "Rx",
    "other_names": [
        "Iopidine"
    ],
    "classes": [
        "Antiglaucoma",
        "Alpha Agonists"
    ],
    "source": "https://reference.medscape.com/drug/iopidine-apraclonidine-343591",
    "pregnancy": {
        "common": [
            "Pregnancy Category: C",
            "Lactation: It is not known if Iopidine is excreted in milk. Decision should be made to discontinue nursing temporarily for the one day on which Iopidine is used."
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: It is not known if Iopidine is excreted in milk. Decision should be made to discontinue nursing temporarily for the one day on which Iopidine is used."
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to apraclonidine, clonidine, or components",
                "Within 14 days of MAO inhibitors administration"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Caution in active cardiac disease, including HTN, coronary insufficiency, recent MI, cerebrovascular disease, chronic renal failure, Raynaud's disease, thromboangiitis obliterans, history of vasovagal attacks",
                "Discontinue if ocular allergic-type reactions develop",
                "Monitor closely if excessive IOP reduction",
                "May impair mental alertness & ability to perform hazardous activities"
            ],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Contraindicated",
            "interaction_with": "isocarboxazid",
            "description": {
                "common": "apraclonidine, isocarboxazid. Mechanism: unknown. Contraindicated. Contraindicated in mfr. prescribing info."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "linezolid",
            "description": {
                "common": "apraclonidine, linezolid. Mechanism: unknown. Contraindicated. Contraindicated in mfr. prescribing info."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "phenelzine",
            "description": {
                "common": "apraclonidine, phenelzine. Mechanism: unknown. Contraindicated. Contraindicated in mfr. prescribing info."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "rasagiline",
            "description": {
                "common": "rasagiline, apraclonidine. Mechanism: unknown. Contraindicated. Apraclonidine should not be used in patients receiving MAO inhibitors."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "selegiline",
            "description": {
                "common": "selegiline, apraclonidine. Mechanism: unknown. Contraindicated. Risk of selegiline-induced hypertension may be increased. Coadministration is contraindicated. Do not coadminister within 14 days of each other."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "selegiline transdermal",
            "description": {
                "common": "selegiline transdermal, apraclonidine. Mechanism: unknown. Contraindicated. Contraindicated in mfr prescribing info."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "tranylcypromine",
            "description": {
                "common": "apraclonidine, tranylcypromine. Mechanism: unknown. Contraindicated. Contraindicated in mfr. prescribing info."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "abametapir",
            "description": {
                "common": "abametapir will increase the level or effect of apraclonidine by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. For 2 weeks after abametapir application, avoid taking drugs that are CYP3A4 substrates. If not feasible, avoid use of abametapir."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Varies with strength",
            "percent": null
        },
        {
            "name": "application",
            "percent": null
        },
        {
            "name": "Ocular adverse effects",
            "percent": null
        },
        {
            "name": "Discomfort",
            "percent": null
        },
        {
            "name": "Hyperemia",
            "percent": null
        },
        {
            "name": "Pruritus",
            "percent": null
        },
        {
            "name": "Blanching",
            "percent": null
        },
        {
            "name": "Blurred vision",
            "percent": null
        },
        {
            "name": "Conjunctivitis",
            "percent": null
        },
        {
            "name": "Discharge",
            "percent": null
        },
        {
            "name": "Dry eyeForeign body sensationLid edema",
            "percent": null
        },
        {
            "name": "Tearing",
            "percent": null
        },
        {
            "name": "Abnormal vision",
            "percent": null
        },
        {
            "name": "Blepharitis",
            "percent": null
        },
        {
            "name": "blepharo",
            "percent": null
        },
        {
            "name": "Conjunctivitis",
            "percent": null
        },
        {
            "name": "Conjunctival",
            "percent": null
        },
        {
            "name": "Edema",
            "percent": null
        },
        {
            "name": "conjunctival follicles",
            "percent": null
        },
        {
            "name": "Corneal erosion",
            "percent": null
        },
        {
            "name": "Corneal infiltrate",
            "percent": null
        },
        {
            "name": "Corneal staining",
            "percent": null
        },
        {
            "name": "EdemaIrritation",
            "percent": null
        },
        {
            "name": "Keratitis",
            "percent": null
        },
        {
            "name": "Keratopathy",
            "percent": null
        },
        {
            "name": "Lid disorder",
            "percent": null
        },
        {
            "name": "Lid erythema",
            "percent": null
        },
        {
            "name": "Lid margin crusting",
            "percent": null
        },
        {
            "name": "Lid retraction",
            "percent": null
        },
        {
            "name": "Lid scales",
            "percent": null
        },
        {
            "name": "Pain",
            "percent": null
        },
        {
            "name": "Photophobia",
            "percent": null
        },
        {
            "name": "Nonocular adverse effects",
            "percent": null
        },
        {
            "name": "Dry mouth",
            "percent": null
        },
        {
            "name": "Arrhythmia",
            "percent": null
        },
        {
            "name": "Facial edema",
            "percent": null
        },
        {
            "name": "Abnormal coordination",
            "percent": null
        },
        {
            "name": "Asthenia",
            "percent": null
        },
        {
            "name": "Depression",
            "percent": null
        },
        {
            "name": "Dizziness",
            "percent": null
        },
        {
            "name": "Headache",
            "percent": null
        },
        {
            "name": "Insomnia",
            "percent": null
        },
        {
            "name": "Malaise",
            "percent": null
        },
        {
            "name": "Nervousness",
            "percent": null
        },
        {
            "name": "Paresthesia",
            "percent": null
        },
        {
            "name": "Parosmia",
            "percent": null
        },
        {
            "name": "Peripheral edema",
            "percent": null
        },
        {
            "name": "Somnolence",
            "percent": null
        },
        {
            "name": "Contact dermatitis",
            "percent": null
        },
        {
            "name": "Dry nose",
            "percent": null
        },
        {
            "name": "Constipation",
            "percent": null
        },
        {
            "name": "Nausea",
            "percent": null
        },
        {
            "name": "Taste perversion",
            "percent": null
        },
        {
            "name": "Myalgia",
            "percent": null
        },
        {
            "name": "Asthma",
            "percent": null
        },
        {
            "name": "Chest pain",
            "percent": null
        },
        {
            "name": "Dyspnea",
            "percent": null
        },
        {
            "name": "Pharyngitis",
            "percent": null
        },
        {
            "name": "Rhinitis",
            "percent": null
        }
    ]
}